MUMBAI, 8 June 2020: Lasa Supergenerics Limited (BSE: 540702; NSE: LASA) has registered a whopping 243.33 percent growth in net profit at INR 2.58 crore for the fourth quarter ended 31 March 2020, as compared to the same Q4 last fiscal year.

The vertically integrated group spanning the entire animal and human healthcare value chain has said in a filing that its earnings before interest, tax, depreciation and amortization (EBITDA)  margins for the fourth quarter was 18.55 percent at , when compared with the third quarter and earnings per share stood at INR 0.89.

For the full year period, the company posted a profit after tax at INR 3.63 crore, as compared to a loss of INR 12.04 crore recorded during 2018-19 fiscal year.

Commenting on the results, Lasa Supergenerics Limited chairman Dr. Omkar Herlekar, ”We are an ambitious and fast growing API company now, moving in the right direction such as foraying into other avenues i.e. steroids, anti-parasites, anti-microbial and ectoparaciticides. Our focus continues to be in anthelmintic where we hold a majority share.”

“The Company under the right leadership and skilled teams have turned net positive to now post a PAT,” Dr Herlekar added.

The company reported an EBITDA of INR 29.95 crore in fiscal year 2019-20, registering a 169.6 percent growth, as against INR 11.11crore in FY19. The Company’s EBITDA margin also improved from 6.55 percent in FY19 to 17.91 percent in FY20, the filing said.

The Company’s FY20 PAT margin stood at a robust 2.17 percent, as against -7.10 percent in FY19, while the finance cost was reduced from INR 8.38 Crore in FY19 to INR 8.10 crore in FY20

Post announcement of Q4 & FY20 results the stock price touched a high of INR 43.25 per share up 10 percent, in result day trade with a volume spurt of 8.43 times.

Lasa Supergenerics has its state of art manufacturing facilities located at Mahad & Chiplun, Maharashtra with a total installed capacity of 4,300 metric tonnes.  The Company has over 25% of APIs exported to counties like Australia, Bangladesh, Middle East, China, Turkey, Egypt, Jordan, Korea, Pakistan etc.

Incorporated in 2011, Lasa Supergenerics Limited is a globally well trusted brand with high quality products, accepted by large companies across the globe. It is a leading players in the manufacturing of Veterinary APIs, with a well-established brand known for its high-quality products amongst various customers.